tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Tonix Pharmaceuticals Holding Corp

TNXP
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
10.750USD
+0.130+1.22%
์ข…๊ฐ€ย 07-23 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
137.47M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

TNXP ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Tonix Pharmaceuticals Holding Corp์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 11, 2026
EPS / ์˜ˆ์ƒ
-2.93/-2.43
์ˆ˜์ต / ์˜ˆ์ƒ
6.88M/6.13M
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
13.11M
29.85%
EPS(YoY)
-14.57
99.92%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/07/23
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-3.28%-2.93
59.64%-3.96
84.32%-3.59
99.80%-3.86
99.52%-2.84
99.64%-9.82
99.61%-22.88
77.50%-1.93K
94.33%-591.07
75.18%-2.74K
---5.84K
---8.57K
---10.42K
---11.04K
---61.18K
----
----
----
----
----
์ˆ˜์ต
183.16%6.88M
108.75%5.39M
16.58%3.29M
-9.51%2.00M
-2.14%2.43M
-31.68%2.58M
-29.26%2.82M
--2.21M
--2.48M
--3.78M
--3.99M
----
----
----
----
----
----
----
----
----
์ˆœ์ด์ต
-138.84%-40.19M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
19.84%-27.32M
3.47%-27.98M
-3.51%-28.36M
-24.94%-33.01M
-15.33%-34.08M
-56.42%-28.98M
-16.31%-27.39M
-27.91%-26.42M
-73.63%-29.55M
-54.53%-18.53M
-66.11%-23.55M
์ˆœ์ด์ต๋ฅ 
15.65%-584.38%
-1.64%-870.32%
-93.18%-972.95%
60.34%-1415.02%
-15.11%-692.84%
-18.43%-856.24%
28.18%-503.65%
---3567.75%
---601.89%
---723.00%
---701.30%
----
----
----
----
----
----
----
----
----
์ด ์ด์ต๋ฅ 
25.96%77.06%
48.33%80.37%
30.19%58.45%
-21.48%-63.76%
84.72%61.18%
45.01%54.18%
10.89%44.90%
---52.49%
--33.12%
--37.36%
--40.49%
----
----
----
----
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
----
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-20.33%4.60%
--8.41%
--12.07%
--6.63%
--5.77%
----
----
----
----
----
----
----
----
----
----
์ˆ˜์ต
183.16%6.88M
108.75%5.39M
16.58%3.29M
-9.51%2.00M
-2.14%2.43M
-31.68%2.58M
-29.26%2.82M
--2.21M
--2.48M
--3.78M
--3.99M
----
----
----
----
----
----
----
----
----
์˜์—… ์ด์ต
-158.73%-41.54M
-114.80%-48.29M
-112.59%-33.07M
-54.13%-28.30M
24.81%-16.05M
17.74%-22.48M
44.74%-15.55M
36.70%-18.36M
37.02%-21.35M
16.50%-27.33M
4.88%-28.15M
-24.28%-29.00M
-28.24%-33.90M
-11.02%-32.73M
-59.65%-29.59M
0.96%-23.34M
-27.49%-26.44M
-73.17%-29.48M
-54.47%-18.54M
-66.02%-23.56M
์ˆœ์ด์ต
-138.84%-40.19M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
19.84%-27.32M
3.47%-27.98M
-3.51%-28.36M
-24.94%-33.01M
-15.33%-34.08M
-56.42%-28.98M
-16.31%-27.39M
-27.91%-26.42M
-73.63%-29.55M
-54.53%-18.53M
-66.11%-23.55M
์œ ๋™์ž์‚ฐ
38.51%207.17M
92.33%228.88M
311.67%208.07M
467.62%143.53M
396.95%149.57M
149.12%119.00M
61.29%50.54M
-50.74%25.29M
-64.05%30.10M
-63.47%47.77M
-79.27%31.34M
-73.23%51.33M
-45.27%83.73M
-30.82%130.78M
-22.53%151.14M
8.17%191.75M
-11.65%152.99M
114.86%189.05M
214.56%195.08M
207.61%177.27M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
144.09%29.65M
68.44%30.84M
38.54%21.03M
-13.53%19.06M
-40.69%12.15M
-3.06%18.31M
-14.39%15.18M
19.53%22.04M
56.65%20.48M
3.87%18.88M
32.93%17.73M
15.92%18.44M
-14.86%13.07M
-16.28%18.18M
10.93%13.34M
96.87%15.91M
154.71%15.35M
121.16%21.72M
174.69%12.03M
72.74%8.08M
์ด ์ž์‚ฐ
33.72%257.91M
70.16%277.17M
165.76%252.44M
166.49%187.36M
42.50%192.87M
5.46%162.89M
-31.80%94.99M
-55.99%70.31M
-24.43%135.34M
-31.56%154.46M
-42.60%139.28M
-42.16%159.74M
-19.95%179.09M
-6.31%225.69M
12.98%242.65M
45.99%276.17M
21.90%223.72M
145.36%240.90M
217.63%214.77M
224.22%189.16M
๋ถ€์ฑ„ ์ด๊ณ„
146.71%30.77M
37.24%32.02M
2.50%21.30M
-31.36%19.36M
-54.14%12.47M
-52.32%23.33M
12.62%20.78M
46.34%28.20M
99.11%27.20M
164.38%48.93M
34.45%18.45M
17.64%19.27M
-13.31%13.66M
-16.57%18.51M
9.29%13.72M
88.92%16.38M
138.59%15.76M
110.56%22.18M
148.68%12.56M
81.69%8.67M
์ž๋ณธ ์ด๊ณ„
25.91%227.14M
75.66%245.15M
211.47%231.14M
299.02%168.00M
66.81%180.40M
32.25%139.56M
-38.58%74.21M
-70.03%42.10M
-34.63%108.14M
-49.07%105.53M
-47.22%120.83M
-45.93%140.46M
-20.45%165.43M
-5.27%207.18M
13.21%228.92M
43.93%259.78M
17.55%207.96M
149.54%218.72M
223.20%202.22M
236.92%180.49M
์ˆœ์˜์—…์ด์ต
-155.25%-42.32M
-171.02%-39.65M
-53.09%-28.78M
-49.54%-14.83M
5.67%-16.58M
34.51%-14.63M
19.60%-18.80M
57.55%-9.92M
46.60%-17.57M
-0.17%-22.34M
0.64%-23.39M
-10.37%-23.37M
-6.01%-32.91M
0.64%-22.30M
-81.79%-23.54M
-10.80%-21.17M
-47.43%-31.05M
-61.31%-22.45M
15.30%-12.95M
-90.30%-19.11M
์ˆœํˆฌ์ž
-28100.00%-1.69M
-33933.33%-1.02M
-10588.89%-962.00K
---2.54M
94.44%-6.00K
99.30%-3.00K
98.90%-9.00K
100.00%0.00
97.16%-108.00K
90.77%-431.00K
90.69%-821.00K
-66.35%-24.02M
81.21%-3.80M
81.77%-4.67M
-13.79%-8.82M
-910.43%-14.44M
-3903.37%-20.22M
-465.11%-25.62M
-93.00%-7.75M
-10107.14%-1.43M
์ˆœ์žฌ๋ฌดํ™œ๋™
-59.21%20.20M
-30.55%59.14M
121.10%94.86M
56.48%10.99M
23464.62%49.53M
109.15%85.15M
583.85%42.91M
582.70%7.03M
98.16%-212.00K
463.20%40.71M
235.65%6.27M
-98.57%1.03M
-188.03%-11.50M
-83.48%7.23M
-112.18%-4.63M
227.35%72.18M
-87.98%13.06M
9.80%43.77M
89.15%37.96M
-35.94%22.05M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Tonix Pharmaceuticals Holding Corp์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 13.11M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 10.09M์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 228.88M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 92.33์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Tonix Pharmaceuticals Holding Corp์˜ ์ด์ž์‚ฐ์€ 277.17M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 70.16์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Tonix Pharmaceuticals Holding Corp์˜ ์ด๋ถ€์ฑ„๋Š” 32.02M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 37.24์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Tonix Pharmaceuticals Holding Corp์˜ ์ด์ž๋ณธ์€ 245.15M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 75.66์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Tonix Pharmaceuticals Holding Corp์˜ ์ˆœ์˜์—…์†Œ๋“์€ -125.70M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -61.69์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Tonix Pharmaceuticals Holding Corp์˜ ์ˆœํˆฌ์ž๋Š” -4.53M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -3673.33์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Tonix Pharmaceuticals Holding Corp์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 214.53M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 59.06์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -14.57์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 99.92์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -124.02M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 4.63์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -946.22์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 26.55์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 49.34์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 113.84์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -64.48์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 39.24์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -56.37์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 31.22์ž…๋‹ˆ๋‹ค.

Tonix Pharmaceuticals Holding Corp์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Tonix Pharmaceuticals Holding Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -125.70M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -61.69์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ